Tolerance Assessment of Tailored 3d-printed TFO With Silicone Interface

Status Not yet recruiting

Clinical Trial Summary

The purpose of this study is to assess the tolerance of tailored 3d-printed transparent face orthosis used in the medical care of post-burn face scar.

Clinical Trial Description

Burn injuries are not a rare affection. According to WHO (World Health Organization), in 2004 there were 11 million peoples in the world who were affected by burn injuries caused by fire and who needed medical cares. This important number ignores non-fire thermal, chemical and electrical burns. Face is one of the most susceptible areas of burn where the prevalence was reported to be 6-60%. Hypertrophic scars (HS) are frequent consequences of dermal burn with a prevalence of 70% of burned people. HS, which are a dermal fibro-proliferation, are rigid, erythematous and thickened scars associated with pigmentation abnormalities, xerosis, thermal sensitivity, pain and pruritus. When HS is located on the face, they can cause cosmetic disorder with disfigurement and psychological distress. Pressure therapy and silicone application are the two recommended non-invasive care for prevention and treatment of hypertrophic scarring after burn. On the face, Pressure Garment Therapy (PGT) cannot exert the required pressure because of concave or flat shape so the use of face mask is the most common form of pressure therapy on the face. The face mask manufacturing is artisanal, time consuming and variable between all burn centers. They are not very accurate and have difficulties to apply effective pressure on certain face areas such as nasolabial folds. Our Transparent Face Orthosis (TFO) uses tri-dimensional cam for measurement and 3d-printing technology for manufacturing. We think this way to manufacture the TFO will be more accurate and efficient, less expansive and time consuming. Moreover, the addition of a silicone interface between the TFO and the face will associate silicone application therapy and pressure therapy what should be more effective than pressure therapy alone. The purpose of this study is to assess the tolerance of tailored 3d-printed transparent face orthosis used in the medical care of post-burn face scar. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04884789
Study type	Interventional
Source	Centre Hospitalier Régional Metz-Thionville
Contact	Nadia OUAMARA, M. Sc, Ing.
Phone	03 87 55 77 52
Email	n.ouamara@chr-metz-thionville.fr
Status	Not yet recruiting
Phase	N/A
Start date	December 1, 2023
Completion date	April 1, 2028

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03664505` - Evaluation of the Product Properties of Individualized 3D-compression Garments to Treat Scars	N/A
Recruiting	`NCT05309720` - Dermal Substitution in Pediatric Burns	N/A
Not yet recruiting	`NCT04995302` - Microneedling Therapy With or Without Amnion Bilayer Sheeting on Scar Tissue	N/A
Not yet recruiting	`NCT04557514` - Comparative Study Between Fat Injection And Platelet Rich Plasma In Post Burn Facial Scar	N/A
Recruiting	`NCT05555602` - Observation of the Comfort and Efficacy of CO2 Laser Combined With Cryo 6 for Burn or Linear Scars.	N/A
Recruiting	`NCT05610878` - Efficacy of Preconditioned Adipose-Derived Stem Cells in Fat Grafting	Phase 1
Recruiting	`NCT01488240` - The Role of Pulsed Dye Laser Therapy in the Management of Burn Scars	N/A
Recruiting	`NCT01619917` - The Role of Fractional Vascular Laser Therapy in the Management of Burn Scars	N/A
Completed	`NCT03197649` - CO2 Laser Phototherapy for Management of Mature Burn Scars	N/A
Completed	`NCT04619589` - Characterization of Dyschromic Hypertrophic Scar
Completed	`NCT03627650` - Fat Grafting in Skin-grafted Deep Burn Scars	N/A
Completed	`NCT02417818` - Cutaneous Microcirculation After Plasma Therapy	N/A
Completed	`NCT02417779` - Cutaneous Microcirculation After Extracorporeal Shock Wave Therapy	N/A
Withdrawn	`NCT01075165` - Efficacy of Spray Silicone in Alteration of Burn Scar	N/A
Recruiting	`NCT04364217` - Pain and Itch Reduction in Burn Scars Treated With Fractional CO2 Laser	N/A
Completed	`NCT04412759` - PORCINE XENOGRAFT OR MICROBIAL CELLULOSE IN THE TREATMENT OF PARTIAL THICKNESS BURNS	N/A
Recruiting	`NCT06122090` - Treatment of Hypopigmented Scars With Bimatoprost	Phase 2
Recruiting	`NCT05423613` - Microneedling for Burn Hypertrophic Scars	N/A
Active, not recruiting	`NCT04456127` - CO2 Laser Revision for Burn Related Donor Site Scars	N/A
Completed	`NCT03544697` - Easy Way of Choosing Rectangular Expander and Getting Maximum Benefit From Expanded Tissue

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Tolerance Assessment of Tailored 3d-printed TFO With Silicone Interface for the Treatment of Post-burn Face Scar — ECORCE

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms